Mahon Paul A's Form 4 filing
United Therapeutics Corp (UTHR) · filed May 30, 2025
- Accession no.
- 0001562180-25-004279
- Filed
- May 30, 2025
- Trade date
- May 29, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 8 non-derivative transactions and 2 derivative transactions. Open-market sales total $3.48M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mahon Paul ACIK 0001231589 | Officer (EVP & GENERAL COUNSEL) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 29, 2025 | Common Stock | MOption exerciseAcquired | +7,000 | $135.42 | +$947,940 | 43,781 | Direct | |
| May 29, 2025 | Common Stock | MOption exerciseAcquired | +4,000 | $117.76 | +$471,040 | 47,781 | Direct | |
| May 29, 2025 | Common Stock | SSaleDisposed | −4,000 | $315.77 | −$1,263,080 | 43,781 | Direct | |
| May 29, 2025 | Common Stock | SSaleDisposed | −99 | $311.14 | −$30,802.86 | 43,682 | Direct | |
| May 29, 2025 | Common Stock | SSaleDisposed | −101 | $313.46F2 | −$31,659.46 | 43,581 | Direct | |
| May 29, 2025 | Common Stock | SSaleDisposed | −1,703 | $315.53F3 | −$537,347.59 | 41,878 | Direct | |
| May 29, 2025 | Common Stock | SSaleDisposed | −4,573 | $316.57F4 | −$1,447,674.61 | 37,305 | Direct | |
| May 29, 2025 | Common Stock | SSaleDisposed | −524 | $317.19F5 | −$166,207.56 | 36,781 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 29, 2025 | Common Stock | MOption exerciseDisposed | −7,000 | $0.00 | $0 | 143,000 | Direct | |
| May 29, 2025 | Common Stock | MOption exerciseDisposed | −4,000 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $312.73 to $313.67. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $315.07 to $316.055. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $316.07 to $317.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $317.11 to $317.46. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.